Sign in

CIK 0001404644 · Non-accelerated filer<br>Smaller reporting company

Neurogene Inc.

Sign in to watch
Ticker
NGNE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
operating
EIN
980542593
Phone
(877) 237-5020
Business address
535 W 24TH STREET, 5TH FLOOR, NEW YORK, NY, 10011
Former names
Neoleukin Therapeutics, Inc., AQUINOX PHARMACEUTICALS, INC, AQUINOX PHARMACEUTICALS (USA) INC
  1. 4 Insider Changes in Ownership
  2. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  3. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  4. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  5. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  6. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  7. 8-K Event Regulation FD disclosure
  8. 424B3 Offering Prospectus
  9. EFFECT Other Notice of Effectiveness
  10. CORRESP Other Correspondence Between Filers and SEC Staff
  11. SC 13G Stake Amended Statement of Ownership
  12. UPLOAD Other SEC-generated Letter
  13. S-1 Offering Registration Statement
  14. 4 Insider Changes in Ownership
  15. 3 Insider Initial Statement of Ownership
  16. SC 13G/A Stake Amended Statement of Ownership
  17. 4 Insider Changes in Ownership
  18. 4 Insider Changes in Ownership
  19. 8-K Event Regulation FD disclosure
  20. 10-Q Report Quarterly Report

Page 6 of 38 · 752 filings